Please select the option that best describes you:

Would you offer systemic chemotherapy to a patient with at least 2023 FIGO stage IC high grade serous (p53-mut) endometrial cancer with extensive LVI for whom nodal assessment was not done?   

Would you offer additional adjuvant treatment (e.g., pelvic EBRT, vaginal brachytherapy, etc.)?



Answer from: at Academic Institution
Sign in or Register to read more

Answer from: Radiation Oncologist at Academic Institution
Sign in or Register to read more

Answer from: Radiation Oncologist at Community Practice
Comments
at H. Lee Moffitt Cancer Center and Research Institute
Curious as to which study you are thinking about f...
Radiation Oncologist at Allegheny Health Network
GOG-0249 showed differences in patterns of failure...
at University of Alabama at Birmingham
I think it is important to note that serous cancer...
Radiation Oncologist at Vanderbilt-Ingram Cancer Center
Chemotherapy does cover the nodes compared to noth...
at University of Alabama at Birmingham
RE: "Chemotherapy does cover the nodes compared to...
Radiation Oncologist at Vanderbilt-Ingram Cancer Center
RE: "I just never understood radiating everyone fo...
Sign in or Register to read more